dc.contributor.advisor | Hashemzadeh, Shahryar | |
dc.contributor.advisor | Zarredar, Habib | |
dc.contributor.author | Mohebbi, Zahra | |
dc.date.accessioned | 2025-04-12T08:22:12Z | |
dc.date.available | 2025-04-12T08:22:12Z | |
dc.date.issued | 2024 | en_US |
dc.identifier.uri | https://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/72246 | |
dc.description.abstract | MicroRNAs (miRNAs) are recognized as an essential controller of gene expression and other activities of the cells. Also, miRNAs have a critical role in the progression and growth of human malignancies. miRNA- 484 and Fis-1 gen have a significant role in lung cancer. The aim of the current study is to determine the expression level of miRNA-484 and Fis-1 gen in NSCLC patients.
Materials and Methods: In this research, forty-five pairs of tumor and non-tumor tissue of NSCLC patients were separated by the surgeon. Then, miRNA-484 and Fis-1 gene expression level in tissues was evaluated. We used TRIzol to extract total RNA from tumor and non-tumor tissues and after that complementary DNA was synthesized. The miRNA-484 and Fis-1 gene expression level was evaluated via the qRT-PCR technique. Moreover, the clinicopathological features of NSCLC patients were evaluated.
Results: We revealed that miRNA-484 and Fis-1 gene expression level was up-regulated and down-regulated in NSCLC tissues in comparison to non-tumor tissues, considerably. Remarkably, the miRNA-484 and Fis-1 gene expression level was considerably correlated to the clinicopathological characteristic of patients including lymph nodes and distant metastasis. | en_US |
dc.language.iso | fa | en_US |
dc.publisher | Tabriz University of Medical Sciences, Faculty of Medicine | en_US |
dc.relation.isversionof | https://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/72245 | en_US |
dc.subject | miRNA-486 | en_US |
dc.subject | Fis-1 | en_US |
dc.subject | NSCLC | en_US |
dc.subject | malignancy | en_US |
dc.subject | Lung | en_US |
dc.title | Evaluation of Fis-1 and miR-484 expression level in tumor samples and healthy tumor margins in lung cancer | en_US |
dc.type | Thesis | en_US |
dc.contributor.supervisor | Nadiri, Mehdi | |
dc.contributor.supervisor | Namvar, Leila | |
dc.identifier.docno | 6011925 | en_US |
dc.identifier.callno | 11925 | en_US |
dc.description.discipline | Internal Medicine | en_US |
dc.description.degree | Specialty Degree | en_US |